Monte Rosa Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLUE and other ETFs, options, and stocks.

About GLUE

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

CEO

Markus Warmuth

CEOMarkus Warmuth

Employees

134

Employees134

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2019

Founded2019

Employees

134

Employees134

GLUE Key Statistics

Market cap

256.50M

Market cap256.50M

Price-Earnings ratio

61.16

Price-Earnings ratio61.16

Dividend yield

—

Dividend yield—

Average volume

402.76K

Average volume402.76K

High today

$4.20

High today$4.20

Low today

$4.02

Low today$4.02

Open price

$4.10

Open price$4.10

Volume

305.72K

Volume305.72K

52 Week high

$12.40

52 Week high$12.40

52 Week low

$3.21

52 Week low$3.21

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

People also own

Based on the portfolios of people who own GLUE. This list is generated using Robinhood data, and it’s not a recommendation.

Recursion Pharmaceuticals